Every year on December 1st, the world commemorates World AIDS Day, raising awareness about HIV and AIDS worldwide. It is a call to action to enable and support communities in their leadership roles. According to the WHO, in 2023, an estimated 39.9 million people were living with HIV globally, and approximately 630,000 people died from HIV‑related causes in 2023.

The new UNAIDS report highlights that the agreed goal of ending AIDS as a public health threat by 2030 can be fulfilled, but only if leaders protect the human rights of everyone living with and at risk of HIV.

The theme of World AIDS Day 2024 is “Take the rights path: My health, my right!” emphasizing that protecting the right to health means ensuring that health care is available to everyone, without any discrimination, regardless of their HIV status, background, or gender. For people with HIV, stigma can create barriers to HIV treatment, viral suppression, and other medical care; addressing and reducing HIV stigma in all its forms remains a major target to ensure proper access to global advances for all.

ISID joins this commemoration that encourages progress in HIV/AIDS prevention, treatment, and care around the world, as well as empowering communities and promoting scientific research and innovation. ISID provides resources related to these recent publications from our journals, the International Journal of Infectious Diseases (IJID) and IJID Regions:

• Real-world effectiveness of COVID-19 vaccine in people with HIV compared with a matched HIV-negative cohort: a test-negative design
• SARS-CoV-2 Serologic Surveillance Among People Living with HIV in Nigeria, April 2022-January 2023
• Kinetics of Hepatitis B Virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to Tenofovir sparing therapy
• Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study
• Suppressed HIV antibody responses following exposure to antiretrovirals—evidence from PrEP randomized trials and early antiretroviral treatment initiation studies
• Initial HIV-1 viral load in French Guiana: Factors associated with viral load set point differences
• Chemsex and rising substance use linked to sexually transmitted infections among men who have sex with men living with HIV in Bangkok, Thailand
• Sexually transmitted and blood-borne infections by sex, methamphetamine use, and houselessness before, at, and after HIV diagnosis in Manitoba, Canada